Showing results (241-250 of 265) with videos related to
Sort By:
Pageof 27
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1991
[Successful treatment of intrapericardial administration of carboplatin in a case of squamous cell lung cancer with malignant pericardial effusion]T Gotoh, Y Fujita, H Uchiyama, et al.Molecular and Cellular Biology|December 1, 1995
Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3GT Gotoh, S Hattori, S Nakamura, et al.The Journal of Antibiotics|October 1, 1982
Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterizationT Gotoh, K Nakahara, T Nishiura, et al.Brain Research|December 11, 1999
Expression of citrulline-nitric oxide cycle in lipopolysaccharide and cytokine-stimulated rat astroglioma C6 cellsW Y Zhang, M Takiguchi, Y Koshiyama, et al.Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|September 1, 1996
Insufficient calcium and iron intakes among general female population in Japan, with special reference to inter-regional differencesS Shimbo, Y Imai, N Tominaga, et al.Cell Death and Differentiation|May 8, 2004
Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosisS Tsutsumi, T Gotoh, W Tomisato, et al.The Histochemical Journal|January 5, 1999
Immunohistochemical localization of arginase II and other enzymes of arginine metabolism in rat kidney and liverK Miyanaka, T Gotoh, A Nagasaki, et al.Experimental & Applied Acarology|April 13, 2010
Reproductive performance of seven strains of the tomato red spider mite Tetranychus evansi (Acari: Tetranychidae) at five temperaturesT Gotoh, N Sugimoto, A Pallini, et al.FEBS Letters|April 12, 2001
CCAAT/enhancer-binding protein beta is required for activation of genes for ornithine cycle enzymes by glucocorticoids and glucagon in primary-cultured hepatocytesT Kimura, S Chowdhury, T Tanaka, et al.Japanese Journal of Clinical Oncology|October 1, 1996
Intrapleural pirarubicin (4'-O-tetrahydropyranyladriamycin) for treatment of malignant pleural effusionT Gotoh, Y Tanaka, Y Fujita, et al.Pageof 27